These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Acute upper gastrointestinal bleeding in critically ill patients: causes and treatment modalities. Conrad SA Crit Care Med; 2002 Jun; 30(6 Suppl):S365-8. PubMed ID: 12072663 [TBL] [Abstract][Full Text] [Related]
44. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Bajaj JS; Dua KS; Hanson K; Presberg K Dig Dis Sci; 2007 Sep; 52(9):2190-4. PubMed ID: 17429726 [TBL] [Abstract][Full Text] [Related]
45. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach? Peterson K; Bjorkman DJ Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876 [TBL] [Abstract][Full Text] [Related]
46. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan. Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780 [TBL] [Abstract][Full Text] [Related]
47. Timing or Dosing of Intravenous Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding Has Low Impact on Costs. Lu Y; Adam V; Teich V; Barkun A Am J Gastroenterol; 2016 Oct; 111(10):1389-1398. PubMed ID: 27140030 [TBL] [Abstract][Full Text] [Related]
48. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113 [TBL] [Abstract][Full Text] [Related]
49. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata. Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754 [TBL] [Abstract][Full Text] [Related]
50. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Spiegel BM; Ofman JJ; Woods K; Vakil NB Am J Gastroenterol; 2003 Jan; 98(1):86-97. PubMed ID: 12526942 [TBL] [Abstract][Full Text] [Related]
51. Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding. Songür Y; Balkarli A; Acartürk G; Senol A Eur J Intern Med; 2011 Apr; 22(2):200-4. PubMed ID: 21402254 [TBL] [Abstract][Full Text] [Related]
52. Management of non-variceal upper gastrointestinal tract hemorrhage: controversies and areas of uncertainty. Trawick EP; Yachimski PS World J Gastroenterol; 2012 Mar; 18(11):1159-65. PubMed ID: 22468078 [TBL] [Abstract][Full Text] [Related]
53. Non-variceal upper GI bleeding in patients already hospitalized for another condition. Müller T; Barkun AN; Martel M Am J Gastroenterol; 2009 Feb; 104(2):330-9. PubMed ID: 19174801 [TBL] [Abstract][Full Text] [Related]
54. Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage? Kim KR; Jun CH; Cho KM; Wi JW; Park SY; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS Korean J Intern Med; 2015 Sep; 30(5):593-601. PubMed ID: 26354053 [TBL] [Abstract][Full Text] [Related]
55. High-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysis. Wu LC; Cao YF; Huang JH; Liao C; Gao F World J Gastroenterol; 2010 May; 16(20):2558-65. PubMed ID: 20503458 [TBL] [Abstract][Full Text] [Related]